GH1 and pituitary tumor: However, at variance with the previous findings, that were mainly focused on inhibition of GH secretion, we are the first to show the in vitro ability of GHRH antagonists to reduce cell viability and growth of PA cells, promoting apoptosis and regulating key signaling pathways involved in pituitary tumor development and progression.